APA (7th ed.) Citation

Minhas, V., Kumar, R., Moitra, T., Singh, R., Panda, A. K., & Gupta, S. K. (2020). Immunogenicity and contraceptive efficacy of recombinant fusion protein encompassing Sp17 spermatozoa‐specific protein and GnRH: Relevance of adjuvants and microparticles based delivery to minimize number of injections. American Journal of Reproductive Immunology, 83(4), 1. https://doi.org/10.1111/aji.13218

Chicago Style (17th ed.) Citation

Minhas, Vidisha, Robin Kumar, Trisha Moitra, Rita Singh, Amulya K. Panda, and Satish Kumar Gupta. "Immunogenicity and Contraceptive Efficacy of Recombinant Fusion Protein Encompassing Sp17 Spermatozoa‐specific Protein and GnRH: Relevance of Adjuvants and Microparticles Based Delivery to Minimize Number of Injections." American Journal of Reproductive Immunology 83, no. 4 (2020): 1. https://doi.org/10.1111/aji.13218.

MLA (9th ed.) Citation

Minhas, Vidisha, et al. "Immunogenicity and Contraceptive Efficacy of Recombinant Fusion Protein Encompassing Sp17 Spermatozoa‐specific Protein and GnRH: Relevance of Adjuvants and Microparticles Based Delivery to Minimize Number of Injections." American Journal of Reproductive Immunology, vol. 83, no. 4, 2020, p. 1, https://doi.org/10.1111/aji.13218.